GenSight Biologics S.A. Profile Avatar - Palmy Investing

GenSight Biologics S.A.

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its pr…

Biotechnology
FR, Paris [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SIGHT.PA's Analysis
CIK: - CUSIP: F4374K117 ISIN: FR0013183985 LEI: - UEI: -
Secondary Listings
SIGHT.PA has no secondary listings inside our databases.